Lightstone Ventures

Lightstone Ventures is a global venture capital firm founded in 2012 that invests in innovative biopharmaceutical and medical technology companies. The firm partners closely with visionary founders to build breakthrough therapies and technologies, focusing on first-in-class drugs and novel medical devices across areas such as oncology, CNS, immunology, ophthalmology, and cardiovascular diseases. Lightstone Ventures provides patient capital and hands-on support from startup through commercialization, leveraging nearly 100 years of combined operational experience and a global footprint with offices in the U.S. and Ireland. Their portfolio includes successful exits and IPOs, demonstrating strong market traction and leadership in life sciences venture capital.